Sectoral Asset Management as of Dec. 31, 2015
Portfolio Holdings for Sectoral Asset Management
Sectoral Asset Management holds 75 positions in its portfolio as reported in the December 2015 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
---|---|---|---|---|---|
Gilead Sciences (GILD) | 7.7 | $180M | 1.8M | 101.19 | |
Alexion Pharmaceuticals | 6.2 | $145M | 758k | 190.75 | |
BioMarin Pharmaceutical (BMRN) | 6.1 | $143M | 1.4M | 104.76 | |
Celgene Corporation | 6.0 | $141M | 1.2M | 119.76 | |
Regeneron Pharmaceuticals (REGN) | 5.5 | $128M | 236k | 542.87 | |
Incyte Corporation (INCY) | 5.2 | $122M | 1.1M | 108.45 | |
Biogen Idec (BIIB) | 3.8 | $89M | 291k | 306.35 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 3.7 | $87M | 688k | 125.83 | |
Thermo Fisher Scientific (TMO) | 3.7 | $86M | 607k | 141.85 | |
Amgen (AMGN) | 3.5 | $82M | 505k | 162.33 | |
Amicus Therapeutics (FOLD) | 3.3 | $77M | 8.0M | 9.70 | |
Merck & Co (MRK) | 2.5 | $59M | 1.1M | 52.82 | |
Seattle Genetics | 2.4 | $57M | 1.3M | 44.88 | |
Acceleron Pharma | 2.3 | $55M | 1.1M | 48.76 | |
Ptc Therapeutics I (PTCT) | 2.2 | $51M | 1.6M | 32.40 | |
Eli Lilly & Co. (LLY) | 2.1 | $51M | 599k | 84.26 | |
Medtronic (MDT) | 1.8 | $42M | 544k | 76.92 | |
Teva Pharmaceutical Industries (TEVA) | 1.7 | $40M | 606k | 65.64 | |
Halozyme Therapeutics (HALO) | 1.5 | $36M | 2.1M | 17.33 | |
Shire | 1.4 | $34M | 165k | 205.00 | |
Intercept Pharmaceuticals In | 1.4 | $33M | 220k | 149.35 | |
Mylan Nv | 1.4 | $33M | 602k | 54.07 | |
Alder Biopharmaceuticals | 1.3 | $31M | 935k | 33.03 | |
United Therapeutics Corporation (UTHR) | 1.3 | $31M | 195k | 156.61 | |
Dex (DXCM) | 1.3 | $30M | 363k | 81.90 | |
Align Technology (ALGN) | 1.1 | $25M | 386k | 65.85 | |
UnitedHealth (UNH) | 1.1 | $25M | 210k | 117.64 | |
St. Jude Medical | 1.1 | $25M | 397k | 61.77 | |
Neurocrine Biosciences (NBIX) | 1.0 | $24M | 417k | 56.57 | |
Ophthotech | 1.0 | $23M | 289k | 78.53 | |
Tesaro | 0.9 | $21M | 405k | 52.32 | |
Cara Therapeutics (CARA) | 0.9 | $20M | 1.2M | 16.86 | |
Edwards Lifesciences (EW) | 0.8 | $20M | 250k | 78.98 | |
Uniqure Nv (QURE) | 0.8 | $19M | 1.1M | 16.54 | |
Tg Therapeutics (TGTX) | 0.8 | $18M | 1.5M | 11.93 | |
Advaxis | 0.8 | $18M | 1.8M | 10.06 | |
Aimmune Therapeutics | 0.8 | $18M | 982k | 18.45 | |
Immune Design | 0.7 | $17M | 857k | 20.08 | |
Intuitive Surgical (ISRG) | 0.7 | $17M | 31k | 546.15 | |
Novo Nordisk A/S (NVO) | 0.7 | $16M | 277k | 58.08 | |
NxStage Medical | 0.7 | $15M | 701k | 21.91 | |
Novartis (NVS) | 0.7 | $15M | 178k | 86.04 | |
Pronai Therapeutics | 0.6 | $14M | 911k | 15.80 | |
Sagent Pharmaceuticals | 0.6 | $13M | 810k | 15.91 | |
HeartWare International | 0.4 | $10M | 204k | 50.40 | |
Adeptus Health Inc-class A | 0.4 | $10M | 188k | 54.52 | |
Teladoc (TDOC) | 0.4 | $10M | 577k | 17.96 | |
Acadia Healthcare (ACHC) | 0.4 | $9.9M | 159k | 62.46 | |
Ionis Pharmaceuticals (IONS) | 0.4 | $9.3M | 150k | 61.93 | |
CIGNA Corporation | 0.4 | $8.4M | 57k | 146.33 | |
Allergan | 0.3 | $6.3M | 20k | 312.50 | |
Regenxbio Inc equity us cm (RGNX) | 0.2 | $5.8M | 351k | 16.60 | |
Dr. Reddy's Laboratories (RDY) | 0.2 | $5.6M | 122k | 46.29 | |
Chimerix (CMRX) | 0.2 | $4.9M | 550k | 8.95 | |
Perrigo Company (PRGO) | 0.2 | $4.3M | 30k | 144.70 | |
Mallinckrodt Pub | 0.2 | $4.0M | 53k | 74.63 | |
Regenxbio | 0.1 | $3.1M | 157k | 19.83 | |
Momenta Pharmaceuticals | 0.1 | $2.8M | 192k | 14.84 | |
Akorn | 0.1 | $2.4M | 64k | 37.31 | |
Nektar Therapeutics (NKTR) | 0.1 | $2.3M | 137k | 16.85 | |
McKesson Corporation (MCK) | 0.1 | $2.1M | 10k | 197.19 | |
Impax Laboratories | 0.1 | $2.0M | 47k | 42.76 | |
Alkermes (ALKS) | 0.1 | $2.1M | 26k | 79.40 | |
Jazz Pharmaceuticals (JAZZ) | 0.1 | $1.9M | 14k | 140.59 | |
Endo International | 0.1 | $1.9M | 31k | 61.23 | |
Eagle Pharmaceuticals (EGRX) | 0.1 | $1.9M | 22k | 88.68 | |
DepoMed | 0.1 | $1.7M | 93k | 18.13 | |
Catalent | 0.1 | $1.5M | 61k | 25.04 | |
Cambrex Corporation | 0.1 | $1.2M | 25k | 47.08 | |
China Biologic Products | 0.0 | $839k | 5.9k | 142.44 | |
Ironwood Pharmaceuticals (IRWD) | 0.0 | $948k | 82k | 11.59 | |
Amphastar Pharmaceuticals (AMPH) | 0.0 | $1.0M | 73k | 14.23 | |
Profound Medical | 0.0 | $598k | 1.0M | 0.58 | |
Coherus Biosciences (CHRS) | 0.0 | $366k | 16k | 22.96 | |
Ascendis Pharma A S (ASND) | 0.0 | $570k | 31k | 18.33 |